Innovation in Anesthesiology Technology, Development, and Commercialization Handbook Clinical and Medical Innovation Series

Innovation in Anesthesiology: Technology, Development, and Commercialization Handbook reflects recent trends of industry globalization and value-conscious healthcare. Written by a team of leading anesthesiologists, engineering development professionals, business analysts, commercialization experts, regulatory and reimbursement specialists, and legal authorities, this volume in the Clinical and Medical Innovation series provides a clear process for the identifi cation, invention, and implementation of new solutions in anesthesiology. This is the ideal resource for anesthesiology innovators who desire to deliver patient solutions and applications to their inventions. Featured case studies on innovative products highlighting the stages required are included for reference.

The book will lead researchers, clinicians, entrepreneurs, and investors through a clear process for the identification, invention, and implementation of new clinical technology solutions. Expert medical device inventor/entrepreneurs provide case studies on globally innovative products including successes, failures and practical advice. The book will be a key reference for entrepreneurs developing emerging technology in anesthesia, investors funding innovation in anesthesia, life science business leaders seeking to understand market trends in technology development, tech transfer offices determining prioritization of patenting dollars, distributors seeking to understand trends in anesthesia technology, as well as researchers and engineers seeking to understand market development needs and trends.

1 Introduction—overview and innovation process flow diagram
2 Technology in anesthesia and perioperative medicine: exploring opportunities and challenges
3 Specific opportunities for innovation in anesthesia
4 Validate, refine, and define the problem to be solved
5 Market analysis—the anesthesia market landsc
6 Competitive analysis
7 Product requirements for emerging anesthesia technologies
8 Partner with a successful expert
9 Conceptualizing idea to solution
10 Prior art searching
11 Patent strategy—patent types and timing
12 Concept testing and selection—where and why will it fail
13 What to prototype?
14 Medical device development
15 Pilot study
16 Clinical research
17 Licensinghow to, terms, expectations, examples for university technology transfer
18 Funding approaches—why, from where, how much, terms
19 Personnel—teams needed, roles
20 Physician entrepreneurship—three steps to success
21 Choosing an entity structure for your business
22 FDA regulation of anesthesia and critical care medical devices
23 Step-by-step guide for Food and Drug Administration listing, 510(k), premarket approval
24 Anesthesia reimbursement
25 Business models
26 Marketing, sales, and distribution
27 Business strategy—valuing emerging technology companies
28 Business operations
29 Post launch physician relationships
30 Innovation in anesthesiology: technology development and commercialization handbook
31 From idea to commercialization: development of a breathing-controlled gaming device for pediatric anesthesia induction
32 Case study: improve the safety and compliance of drug preparation and administration with barcode technology
33 Revolutionizing blood transfusion: HemaLogiX-optimizing clinical appropriateness and resource utilization
34 FirstLook LTA from Guidance Airway Solut

Adam E. M. Eltorai, MD, PhD completed his graduate studies in Biomedical Engineering and Biotechnology along with his medical degree from Brown University. His work has spanned the translational spectrum with a focus on medical technology innovation and development. Dr. Eltorai has published numerous articles and books.

Ms. Patterson is a Venture Analyst and the President and CEO and Founder of Strategy Inc. (in 2000) for global clients. Ms. Patterson has operational experience leading companies to be acquired by medical multinationals for up to $508M. Ms. Patterson has held the position as the Vice President, Commercialization for the Alfred Mann Foundation for Biomedical Engineering identifying entities to be awarded investments from the $2B fund. From 2006 to 2015, she was a guest lecturer in the Medical School at the UCLA core Business of Science program. This graduate school program, one of the most popular in the medical school, teaches about the path to successful commercialization for life science technology. Ms. Patterson is an immunologist from University of Michigan and also has an MBA from University of Southern California.